Shopping Cart
Remove All
Your shopping cart is currently empty
Briakinumab (ABT-874) is a monoclonal antibody targeting IL-12, used in the study of psoriasis, rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $228 | In Stock | In Stock | |
| 5 mg | $562 | In Stock | In Stock | |
| 10 mg | $845 | - | In Stock | |
| 25 mg | $1,250 | - | In Stock | |
| 50 mg | $1,680 | - | In Stock |
| Description | Briakinumab (ABT-874) is a monoclonal antibody targeting IL-12, used in the study of psoriasis, rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis. |
| Targets&IC50 | FcRn:0.27 μM (Kd) |
| In vitro | The affinity of Briakinumab to FcRn was Kd = 0.27μM. [1] |
| In vivo | Administering Briakinumab to FcRn knockout (KO) mice via a tail vein, the Briakinumab treated group showed faster clearance compared to wild-type mice. [1] |
| Synonyms | J 695, BSF415977, BSF 415977, ABT-874, ABT874, A-796874.0 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Host Species | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Cas No. | 339308-60-0 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.